On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from Kenneth Steiner, on the adoption of a Board policy that the Chairperson of the Board be an independent director was not approved.
Market Closed -
Other stock markets
|
Pre-market 07:00:11 am | |||
41.54 USD | -1.89% | 41.72 | +0.45% |
May. 23 | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
May. 22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.04% | 84.21B | |
+38.69% | 728B | |
+33.05% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+16.00% | 244B | |
+7.69% | 207B | |
-5.56% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company